Catalase-negative Staphylococcus aureus septicaemia.
Turner
D P
DP
Pye
S M
SM
Taylor
R E
RE
D000212:Acyclovir / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D016470:Bacteremia / Q000188:drug therapy* / Q000382:microbiology; D002374:Catalase; D002404:Catheterization / Q000009:adverse effects; D002481:Cellulitis / Q000188:drug therapy / Q000382:microbiology*; D003288:Contusions / Q000150:complications / Q000628:therapy; D005260:Female; D005436:Floxacillin / Q000627:therapeutic use; D006406:Hematoma / Q000150:complications / Q000628:therapy; D006560:Herpes Labialis / Q000150:complications / Q000188:drug therapy; D006801:Humans; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000150:complications* / Q000503:physiopathology; D010406:Penicillins / Q000627:therapeutic use; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000382:microbiology; D013211:Staphylococcus aureus / Q000201:enzymology / Q000302:isolation & purification* / Q000472:pathogenicity
D000998:Antiviral Agents; D010406:Penicillins; D005436:Floxacillin; D002374:Catalase; D000212:Acyclovir